LIPO-202 + Placebo
Phase 3Completed 0 watching 0 views this week📈 Rising
69
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Central Abdominal Bulging
Conditions
Central Abdominal Bulging
Trial Timeline
Apr 9, 2015 → Oct 29, 2015
NCT ID
NCT02398188About LIPO-202 + Placebo
LIPO-202 + Placebo is a phase 3 stage product being developed by Evofem Biosciences for Central Abdominal Bulging. The current trial status is completed. This product is registered under clinical trial identifier NCT02398188. Target conditions include Central Abdominal Bulging.
Hype Score Breakdown
Clinical
27
Activity
18
Company
2
Novelty
9
Community
10
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02483533 | Phase 3 | Terminated |
| NCT02398188 | Phase 3 | Completed |
Competing Products
20 competing products in Central Abdominal Bulging